CAS: 338992-00-0 - Vandetanib
Formula:C22H24BrFN4O2
InChI:InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)
InChI key:InChIKey=UHTHHESEBZOYNR-UHFFFAOYSA-N
SMILES:FC1=CC(Br)=CC=C1NC=2N=CN=C3C=C(OCC4CCN(C)CC4)C(OC)=CC32
- Synonyms:
- N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine
- 4-(4-Bromo-2-fluoroanilino)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazoline
- Vandetanib
- 4-Quinazolinamine, N-(4-bromo-2-fluorophenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-
- ZD 6474
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Vandetanib Fumarate REF: TM-T1656LCAS: 338992-00-0 | 98% | 997.00 €~2,609.00 € | Tue 25 Feb 25 |
Vandetanib Fumarate
CAS:338992-00-0
Oral tyrosine kinase inhibitor Vandetanib Fumarate targets RET, VEGFRs, EGFR in thyroid cancer.
Formula:
C26H28BrFN4O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
591.43
Ref: TM-T1656L
25mg | 1,549.00 € | ||
50mg | 2,031.00 € | ||
100mg | 2,609.00 € |
Estimated delivery in United States, on Tuesday 25 Feb 2025